Amphastar Pharmaceuticals(AMPH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AMPH Amphastar Pharmaceuticals

交易中 11-22 13:08:52 EST

45.46

+0.91

+2.04%

最高45.57	最低44.95	成交量16.71万
今开45.48	昨收44.55	日振幅1.39%
总市值21.86亿	流通市值16.98亿	总股本4,808万
成交额755.21万	换手率0.45%	流通股本3,735万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AMPH","market":"US","secType":"STK","nameCN":"Amphastar Pharmaceuticals","latestPrice":45.46,"timestamp":1732298924987,"preClose":44.55,"halted":0,"volume":167092,"delay":0,"floatShares":37353667,"shares":48081433,"eps":3.009147,"marketStatus":"交易中","marketStatusCode":2,"change":0.91,"latestTime":"11-22 13:08:52 EST","open":45.48,"high":45.569,"low":44.95,"amount":7552094.552608,"amplitude":0.013895,"askPrice":45.48,"askSize":301,"bidPrice":45.42,"bidSize":6,"shortable":3,"etf":0,"ttmEps":3.009147,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1403668800000,"adjPreClose":44.55,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":45.28,"preClose":44.55,"latestTime":"09:28 EST","volume":195,"amount":8802.829425,"timestamp":1732285680112},"postHourTrading":{"tag":"盘后","latestPrice":44.55,"preClose":44.55,"latestTime":"16:20 EST","volume":29967,"amount":1335029.85,"timestamp":1732224040842},"volumeRatio":0.690201,"impliedVol":0.8393,"impliedVolPercentile":0.9643},"requestUrl":"/m/hq/s/AMPH","defaultTab":"news","newsList":[{"id":"2483306184","title":"Amphastar Pharmaceuticals, Inc.2024财年第三财季实现净利润40.43百万美元，同比减少17.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306184?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686429,"startTime":"0","endTime":"0","summary":"11月16日，Amphastar Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为40.43百万美元，同比减少17.86%；其中营业收入为1.91亿美元，同比增加5.52%，每股基本收益为0.83美元。从资产负债表来看，Amphastar Pharmaceuticals, Inc.总负债8.18亿美元，其中短期债务4.46百万美元，资产负债比为1.89，流动比率为3.44。机构评级：截至2024年11月16日，当前有4家机构对Amphastar Pharmaceuticals, Inc.目标价做出预测，其中目标均价为59.00美元，其中最低目标价为55.00美元，最高目标价为66.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000214a23b88ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000214a23b88ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMPH"],"gpt_icon":0},{"id":"1165981946","title":"异动解读 | Amphastar Pharmaceuticals股价大涨 市场关注业绩增长和未来前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1165981946","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165981946?lang=zh_cn&edition=full","pubTime":"2024-11-09 03:04","pubTimestamp":1731092672,"startTime":"0","endTime":"0","summary":"北京时间11月8日,制药公司Amphastar Pharmaceuticals股价在交易中大涨5.28%,引发市场广泛关注。公司最新财报数据显示,Amphastar Pharmaceuticals实现营业收入1.91亿美元,净利润4043万美元,每股收益0.83美元,毛利1.08亿美元,业绩表现出色。市场分析人士认为,公司业绩增长及良好的盈利能力有望持续推动股价上涨。此外,有分析指出,机构看好Amphastar Pharmaceuticals的前景。作为一家专注于仿制药和特殊用药的公司,Amphastar Pharmaceuticals在医院和紧急护理领域具有广阔的市场机会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Amphastar Pharmaceuticals股价大涨 市场关注业绩增长和未来前景","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMPH"],"gpt_icon":0},{"id":"2482431341","title":"Amphastar Pharmaceuticals, Inc.盘中异动 急速上涨5.10%报48.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482431341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482431341?lang=zh_cn&edition=full","pubTime":"2024-11-09 02:39","pubTimestamp":1731091180,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日02时39分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.10%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为2.80%。其相关个股中，Incannex Healthcare Inc.、德纳维制药、Esperion Therapeutics, Inc.涨幅较大，Evoke Pharma, Inc.、Biofrontera Inc.、Canopy Growth Corporation较为活跃，换手率分别为18.78%、10.60%、5.65%，振幅较大的相关个股有Assertio Holdings, Inc.、Quantum Biopharma Ltd.、Aytu Biopharma, Inc.，振幅分别为23.26%、19.91%、18.26%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110902394098e418c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110902394098e418c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4588","BK4557","AMPH","BK4585"],"gpt_icon":0},{"id":"1154453366","title":"异动解读 | 阿霞制药公司股价大跌逾13% 第三季度业绩未达预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1154453366","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154453366?lang=zh_cn&edition=full","pubTime":"2024-11-08 11:01","pubTimestamp":1731034883,"startTime":"0","endTime":"0","summary":"2024年11月7日,阿霞制药公司股价大幅下跌13.52%,引发市场关注。公司此前披露的2024财年第三季度财报显示,营收及利润均未达分析师预期,这被认为是导致股价重挫的主因。具体来看,阿霞制药第三季度调整后每股收益为0.96美元,低于分析师平均预期的0.99美元;营收同比增长5.9%至1.91亿美元,但也未达预期的1.95亿美元。值得注意的是,过去三个月内,分析师对阿霞制药未来盈利预期有所下调,平均预期下降约2.8%。阿霞制药今年迄今股价累计下跌16.6%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMPH"],"gpt_icon":0},{"id":"1159218207","title":"异动解读 | 阿霞制药公司股价大跌逾10% 第三季度营收利润未达预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1159218207","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159218207?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:36","pubTimestamp":1730990208,"startTime":"0","endTime":"0","summary":"阿霞制药公司11月7日早盘大跌10.22%,引发市场广泛关注。公司近期披露的2024财年第三季度财报显示,营收及利润均未达分析师预期,或是引发投资者担忧的主因。根据财报数据,阿霞公司第三季度调整后每股收益为0.96美元,低于分析师平均预期的0.99美元。营收同比增长5.9%至1.91亿美元,但也未达预期的1.95亿美元。第三季度净收入为4,043万美元。过去三个月内,分析师对阿霞公司未来盈利预期有所下调,平均预期下降约2.8%。阿霞制药今年迄今股价累计下跌16.6%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMPH"],"gpt_icon":0},{"id":"2481186062","title":"Amphastar Pharmaceuticals, Inc.股价重挫10.64% 市值跌2.46亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481186062","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481186062?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:32","pubTimestamp":1730989956,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日22时32分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价急速下跌10.64%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.71%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110722323695bde661&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110722323695bde661&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","BK4588","BK4557","AMPH"],"gpt_icon":0},{"id":"1186101343","title":"异动解读 | Amphastar Pharmaceuticals第三季度业绩疲软引发股价大跌逾10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186101343","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186101343?lang=zh_cn&edition=full","pubTime":"2024-11-07 13:12","pubTimestamp":1730956376,"startTime":"0","endTime":"0","summary":"Amphastar Pharmaceuticals公司在上交所正常交易时段内大跌10.71%,引发市场广泛关注。公司此前公布的第三季度财报显示,由于业绩疲弱未达预期,或引发了投资者担忧情绪,推动股价大跌。根据财报,该公司第三季度调整后每股收益为0.96美元,低于去年同期的1.15美元,也未达到分析师预期的0.99美元。过去三个月内,平均盈利预期下降约2.8%。不过本次财报疲软表现可能加剧市场对其成长前景的担忧,推动股价大跌。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Amphastar Pharmaceuticals第三季度业绩疲软引发股价大跌逾10%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMPH"],"gpt_icon":0},{"id":"2481867911","title":"Amphastar Pharmaceuticals Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481867911","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481867911?lang=zh_cn&edition=full","pubTime":"2024-11-07 12:05","pubTimestamp":1730952317,"startTime":"0","endTime":"0","summary":"Amphastar Pharmaceuticals Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要Amphastar Pharmaceuticals Inc AMPH.OQ 公布的截至 9 月 30 日的季度调整后每股收益为 96 美分，低于去年同期的每股收益 1.15 美元。华尔街预期为每股收益 89 美分至 1.13 美元。Amphastar Pharmaceuticals Inc公布的本季度每股收益为78美分。公司报告的季度净收入为 4,043 万美元。Amphastar Pharmaceuticals Inc 的股价本季度上涨了 6.2%，今年迄今为止下跌了 16.6%。华尔街对 Amphastar Pharmaceuticals Inc 的 12 个月目标价中位数为 55.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL4S3ME0C6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4007","BK4557","BK4588","AMPH"],"gpt_icon":0},{"id":"2460824927","title":"Amphastar Pharmaceuticals, Inc.2024财年第二财季实现净利润37.95百万美元，同比增加45.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460824927","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460824927?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824013,"startTime":"0","endTime":"0","summary":"8月17日，Amphastar Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为37.95百万美元，同比增加45.29%；其中营业收入为1.82亿美元，同比增加24.66%，每股基本收益为0.78美元。从资产负债表来看，Amphastar Pharmaceuticals, Inc.总负债7.78亿美元，其中短期债务4.25百万美元，资产负债比为1.92，流动比率为3.53。机构评级：截至2024年8月17日，当前有5家机构对Amphastar Pharmaceuticals, Inc.目标价做出预测，其中目标均价为59.80美元，其中最低目标价为48.00美元，最高目标价为70.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170001289f31ac95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170001289f31ac95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMPH"],"gpt_icon":0},{"id":"2459403564","title":"Amphastar Pharmaceuticals, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459403564","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459403564?lang=zh_cn&edition=full","pubTime":"2024-08-16 01:18","pubTimestamp":1723742339,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日01时18分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.00%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为0.41%。其相关个股中，Alvotech C/Wts 、Shuttle Pharmaceuticals Holdings, Inc.、Emergent Biosolutions, Inc.涨幅较大，Siga Technologies Inc.、Sunshine Biopharma Inc.、Emergent Biosolutions, Inc.较为活跃，换手率分别为17.24%、14.47%、5.20%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、Emergent Biosolutions, Inc.、Siga Technologies Inc.，振幅分别为43.66%、19.35%、17.96%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081601185997198db8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081601185997198db8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4007","BK4557","BK4588","AMPH"],"gpt_icon":0},{"id":"1135024562","title":"异动解读 | Amphastar Pharmaceuticals股价大涨13.36% 分析师下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1135024562","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135024562?lang=zh_cn&edition=full","pubTime":"2024-08-09 16:06","pubTimestamp":1723190768,"startTime":"0","endTime":"0","summary":"Amphastar Pharmaceuticals公司股价在8月8日盘中大涨13.36%,引发市场广泛关注。分析人士认为,这可能与分析师下调该公司目标价有关。\n\n据路透社报道,Piper Sandler分析师将Amphastar Pharmaceuticals的目标价从71美元下调至66美元。这可能导致部分投资者对该公司前景的预期下降,从而引发股价下跌。\n\n不过,也有分析师对该公司持乐观态度。在所有6家参与评级的机构中,67%的券商给予买入建议,33%的券商给予持有建议,无券商给予卖出建议。这表明多数分析师对该公司未来发展前景保持信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMPH"],"gpt_icon":0},{"id":"2458441813","title":"美国研究综述-Amphastar Pharmaceuticals、G1 Therapeutics、Upwork","url":"https://stock-news.laohu8.com/highlight/detail?id=2458441813","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458441813?lang=zh_cn&edition=full","pubTime":"2024-08-09 00:55","pubTimestamp":1723136129,"startTime":"0","endTime":"0","summary":"    路透8月8日 - 华尔街证券分析师周四调整了对 Amphastar Pharmaceuticals、G1 Therapeutics 和 Upwork 等几家美国上市公司的评级和目标价。要点  * Amphastar Pharmaceuticals Inc   ：Piper Sandler 将目标价从 71 美元下调至 66 美元 * Charles River Laboratories International Inc   ：贝雅下调目标价至中性 * G1 Therapeutics Inc   ：H.C. Wainwright将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMPH","BCSF","BXSL","ALIT","LU1599440770.SGD","ATEX","ASLE","ALLO","ADUS","BLBD","LU2264538146.SGD","LU2430703251.USD","LU2430703178.SGD","AZEK","ALEX","ATGE","ACAD","BARK","LU0823414478.USD","BK4107","AEVA","ARKO","BDSX","ASH","LU0566484027.USD","BLNK","CAR","ALB","BYND","ASIX","AGCO","TCPC","IE00B19Z9P08.USD","ALLK","AADI","BOOT","BWMN","AKA","LENZ","LU1244550577.SGD","AZPN","CE","BK4109","BLK","AIZ","LU2430703095.HKD","APLS","ACM","CELH","APP"],"gpt_icon":1},{"id":"2457631166","title":"Amphastar Pharmaceuticals, Inc.盘中异动 早盘股价大涨12.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457631166","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457631166?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:32","pubTimestamp":1723123965,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时32分，Amphastar Pharmaceuticals, Inc.股票出现波动，股价急速上涨12.75%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为6.54%。其相关个股中，Harrow, Inc.、Rockwell Medical, Inc.、礼来涨幅较大，Fsd Pharma Inc.、Sunshine Biopharma Inc.、Harrow, Inc.较为活跃，换手率分别为1.89%、1.24%、1.17%，振幅较大的相关个股有Elanco Animal Health Incorporated、Harrow, Inc.、Ironwood医药，振幅分别为7.92%、7.69%、7.49%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080821324595890089&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080821324595890089&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","AMPH","BK4557","BK4007","BK4588"],"gpt_icon":0},{"id":"2457936218","title":"美国研究综述-Amphastar Pharmaceuticals、Guardant Health、Upwork","url":"https://stock-news.laohu8.com/highlight/detail?id=2457936218","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457936218?lang=zh_cn&edition=full","pubTime":"2024-08-08 17:59","pubTimestamp":1723111176,"startTime":"0","endTime":"0","summary":"    路透8月8日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Amphastar Pharmaceuticals、Guardant Health 和 Upwork。要点  * Amphastar Pharmaceuticals Inc   ：Piper Sandler将目标价从71美元下调至66美元 * Charles River Laboratories International Inc   ：贝尔德下调目标价至中性 * Guardant Health Inc   ：Leerink Partners将目标价从40美元上调至60美元 * Treehouse Foods Inc   ：杰富瑞将目标价从39美元上调至43美元 * Upwork Inc   ：Piper Sandler将目标价从20美元下调至13美元 以下是路透周四报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CE","AZPN","BWMN","CSGS","BK4592","CVX","DIN","BOOT","AGCO","DH","BK4505","LU0640476718.USD","LU1244550494.USD","BHF","ADUS","ATEX","DE","BMBL","ALLK","LU0471298777.SGD","BARK","CVS","AMPH","IE00BD6J9T35.USD","H","AZEK","ALB","BSIG","BK4524","BROS","CRL","CPAY","AKA","AADI","CENT","CERT","SG9999004303.SGD","BK4588","TCPC","BLK","LU0320765489.SGD","CNS","DUOL","ASH","AIZ","DK","BXSL","CIM"],"gpt_icon":1},{"id":"2457767617","title":"Amphastar Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.04%报39.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457767617","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457767617?lang=zh_cn&edition=full","pubTime":"2024-08-05 22:00","pubTimestamp":1722866407,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日22时00分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.04%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为3.19%。其相关个股中，Painreform Ltd.、Scilex Holding Company C/Wts 10/11/2027 、Therapeuticsmd, Inc.涨幅较大，苏轩堂、Akanda Corp.、Painreform Ltd.较为活跃，换手率分别为14.78%、14.68%、10.28%，振幅较大的相关个股有Durect Corporation、Painreform Ltd.、Mira Pharmaceuticals, Inc.，振幅分别为17.11%、17.09%、15.20%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080522000798e34c17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080522000798e34c17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMPH","BK4588","BK4007","BK4585","BK4557"],"gpt_icon":0},{"id":"2450390395","title":"Amphastar Pharmaceuticals, Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450390395","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450390395?lang=zh_cn&edition=full","pubTime":"2024-07-12 03:25","pubTimestamp":1720725949,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日03时25分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.08%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为0.11%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。消息层面，截至03时25分，《美银证券维持Amphastar Pharmaceuticals持有评级》资讯为影响Amphastar Pharmaceuticals, Inc.的重要信息。该信息摘要如下：美银证券分析师Jason Gerberry维持$Amphastar Pharmaceuticals $持有评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407120325499681c14d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407120325499681c14d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMPH","BK4588","BK4007","BK4585","BK4557"],"gpt_icon":0},{"id":"2448915363","title":"Amphastar Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.23%报37.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448915363","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448915363?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:45","pubTimestamp":1719841503,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时45分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价快速下跌6.23%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.68%。消息层面，截至21时45分，《Form 144 | Amphastar Pharmaceuticals高管拟出售3,596股股份，价值约14.46万美元》资讯为影响Amphastar Pharmaceuticals, Inc.的重要信息。该信息摘要如下：根据美国证券交易委员会美东时间6月27日披露的文件，$Amphastar Pharmaceuticals $高管PETERS WILLIAM J拟于6月27日出售3,596股普通股股份，总市值约14.46万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701214504968186e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701214504968186e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4585","BK4588","BK4007","AMPH"],"gpt_icon":0},{"id":"2446557293","title":"Piper Sandler：重申Amphastar Pharma(AMPH.US)评级，由增持调整至增持评级, 目标价由71.","url":"https://stock-news.laohu8.com/highlight/detail?id=2446557293","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446557293?lang=zh_cn&edition=full","pubTime":"2024-06-28 23:59","pubTimestamp":1719590381,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AMPH","BK4588","BK4007","BK4585","BK4557"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amphastar.com","stockEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":-0.1157},{"period":"3month","weight":-0.0709},{"period":"6month","weight":0.0298},{"period":"1year","weight":-0.2052},{"period":"ytd","weight":-0.2797}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amphastar Pharmaceuticals, Inc.是一家加利福尼亚的公司，成立于1996年2月29日，于2004年7月和amphastar制药公司一家在特拉华成立的公司合并。公司是一家专业制药公司，主要开发，生产，销售市场上通用和专用注射和吸入产品，包括投资组合的市场进入壁垒高，通用和专利产品。大多数公司的产品用于住院或紧急护理的临床设置和主要承包通过集团采购组织和药品批发商。公司的产品主要分布在药企零售。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.032241},{"month":2,"riseRate":0.4,"avgChangeRate":-0.000914},{"month":3,"riseRate":0.6,"avgChangeRate":0.041364},{"month":4,"riseRate":0.5,"avgChangeRate":0.008115},{"month":5,"riseRate":0.8,"avgChangeRate":0.069021},{"month":6,"riseRate":0.7,"avgChangeRate":0.072694},{"month":7,"riseRate":0.545455,"avgChangeRate":0.002784},{"month":8,"riseRate":0.545455,"avgChangeRate":0.018411},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.038383},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.008156},{"month":11,"riseRate":0.727273,"avgChangeRate":0.070957},{"month":12,"riseRate":0.4,"avgChangeRate":0.020732}],"exchange":"NASDAQ","name":"Amphastar Pharmaceuticals","nameEN":"Amphastar Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amphastar Pharmaceuticals(AMPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Amphastar Pharmaceuticals(AMPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Amphastar Pharmaceuticals,AMPH,Amphastar Pharmaceuticals股票,Amphastar Pharmaceuticals股票老虎,Amphastar Pharmaceuticals股票老虎国际,Amphastar Pharmaceuticals行情,Amphastar Pharmaceuticals股票行情,Amphastar Pharmaceuticals股价,Amphastar Pharmaceuticals股市,Amphastar Pharmaceuticals股票价格,Amphastar Pharmaceuticals股票交易,Amphastar Pharmaceuticals股票购买,Amphastar Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amphastar Pharmaceuticals(AMPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Amphastar Pharmaceuticals(AMPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}